U.S. Patent Office issues patent for BIODEL, a biodegradable polymer, which contains a chemotherapeutic drug. The patent covers claims for the high molecular weight polyanhydrides, which can be used for controlling the release of pharmaceuticals. The company has the exclusive worldwide license for the technology from the Massachusetts Institute of Technology. BIODEL is now involved in clinical testing in five U.S. medical centers.
You may also be interested in...
Washington State Ecology Mulls ‘Safer’ Definition While Exploring Phthalate Alternatives In Fragrances
Marissa Smith, senior regulatory toxicologist in the Washington Department of Ecology’s Hazardous Waste and Toxics Reduction program, discusses what’s next for the state’s inaugural Safer Products go-round. “How we define ‘safer’ is really going to be the lynchpin of this whole process,” she says.
Class action complaints filed in 2020 against food, dietary supplement and beverage firms should pass 2019’s total as COVID-19 has not slowed litigants but has given plaintiffs’ council more time out of court to shop for new cases.
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.